Literature DB >> 15855328

Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells.

Sylvaine You1, Mériam Belghith, Stephen Cobbold, Marie-Alexandra Alyanakian, Christine Gouarin, Samia Barriot, Corinne Garcia, Herman Waldmann, Jean-François Bach, Lucienne Chatenoud.   

Abstract

Diabetogenic T-cells can be detected in pre-diabetic nonobese diabetic (NOD) mice after transfer in NOD-SCID recipients. Here we demonstrate that 6-week-old pre-diabetic NOD mice, >2 months before disease onset, already harbor pathogenic T-cells in equal numbers to overtly diabetic animals. The delay in diabetes appearance is explained by the presence of regulatory CD4+ CD25+ T-cells that control diabetogenic effectors and that are, in our hands, transforming growth factor (TGF)-beta-dependent. Our present results suggest, however, that diabetes onset is only partly explained by a decline in this regulatory T-cell activity. Another major factor appears to be the progressive resistance of diabetogenic cells to TGF-beta-dependent mediated inhibition. We propose that progression to overt disease correlates with the pathogenic T-cell's escape from TGF-beta-dependent T-cell-mediated regulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855328     DOI: 10.2337/diabetes.54.5.1415

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  95 in total

1.  CD19+IgM+ cells demonstrate enhanced therapeutic efficacy in type 1 diabetes mellitus.

Authors:  Andrew D Vonberg; Maria Acevedo-Calado; Aaron R Cox; Susan L Pietropaolo; Roberto Gianani; Steven K Lundy; Massimo Pietropaolo
Journal:  JCI Insight       Date:  2018-12-06

2.  Role of IFN-γ in the establishment of anterior chamber-associated immune deviation (ACAID)-induced CD8+ T regulatory cells.

Authors:  Kathryn Paunicka; Peter W Chen; Jerry Y Niederkorn
Journal:  J Leukoc Biol       Date:  2011-12-16       Impact factor: 4.962

Review 3.  Mixed chimerism and split tolerance: mechanisms and clinical correlations.

Authors:  David P Al-Adra; Colin C Anderson
Journal:  Chimerism       Date:  2011 Oct-Dec

4.  The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors.

Authors:  Anna Morena D'Alise; Vincent Auyeung; Markus Feuerer; Junko Nishio; Jason Fontenot; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

5.  Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes.

Authors:  J M Lawson; J Tremble; C Dayan; H Beyan; R D G Leslie; M Peakman; T I M Tree
Journal:  Clin Exp Immunol       Date:  2008-12       Impact factor: 4.330

6.  Amplification of autoimmune response through induction of dendritic cell maturation in inflamed tissues.

Authors:  Kristin Melli; Rachel S Friedman; Ashley E Martin; Erik B Finger; Gang Miao; Gregory L Szot; Matthew F Krummel; Qizhi Tang
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

7.  Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes.

Authors:  Markus Feuerer; Wenyu Jiang; Phillip D Holler; Ansuman Satpathy; Christopher Campbell; Molly Bogue; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-08       Impact factor: 11.205

8.  Altered connexin 43 expression underlies age-dependent decrease of regulatory T cell suppressor function in nonobese diabetic mice.

Authors:  Michal Kuczma; Cong-Yi Wang; Leszek Ignatowicz; Robert Gourdie; Piotr Kraj
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

Review 9.  Restoring Regulatory T Cells in Type 1 Diabetes.

Authors:  Allyson Spence; Qizhi Tang
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

10.  CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice.

Authors:  Cheng Ye; Benjamin E Low; Michael V Wiles; Todd M Brusko; David V Serreze; John P Driver
Journal:  J Immunol       Date:  2020-08-31       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.